Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INTERFERON BETA-1B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ossege, LM; Sindern, E; Patzold, T; Malin, JP
      Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Opdenakker, G; Van den Steen, PE; Van Damme, J
      Gelatinase B: a tuner and amplifier of immune functions

      TRENDS IN IMMUNOLOGY
    3. Amato, MP; Ponziani, G; Rossi, F; Liedl, CL; Stefanile, C; Rossi, L
      Quality of life in multiple sclerosis: the impact of depression, fatigue and disability

      MULTIPLE SCLEROSIS
    4. Richert, ND; Ostuni, JL; Bash, CN; Leist, TP; McFarland, HF; Frank, JA
      Interferon beta-1b and intravenous methylprednisolone promote lesion recovery in multiple sclerosis

      MULTIPLE SCLEROSIS
    5. Khan, OA; Tselis, AC; Kamholz, JA; Garbern, JY; Lewis, RA; Lisak, RP
      A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFN beta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

      EUROPEAN JOURNAL OF NEUROLOGY
    6. Waubant, E; Gee, L; Miller, K; Stabler, G; Goodkin, D
      IFN-beta 1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    7. Gelati, M; Corsini, E; Dufour, A; Zaffaroni, M; Milanese, C; La Mantia, L; Massa, G; Salmaggi, A
      Transmigration of PBMNCs from beta-IFN-lb-treated MS patients: a one-year longitudinal study

      AUTOIMMUNITY
    8. Stock, G; Horowski, R
      A brief history of beta interferon therapy in multiple sclerosis

      MEDIZINISCHE KLINIK
    9. Haupts, M; Pohlau, D; von Schayck, R; Storch-Hagenlocher, B; Sartor, K; Gehlen, W
      New aspects of MS therapy with glatiramer acetate - An update review

      AKTUELLE NEUROLOGIE
    10. Lebrun, C
      Indications for symptomatic treatment of cognitive and psychopathological disorders in multiple sclerosis

      REVUE NEUROLOGIQUE
    11. Oentrich, W; Dose, T; Friedmann, D; Haupts, M; Haller, P; Hartung, HP; Walther, EU; Konig, N; Schroder, G; Sturzebecher, CS
      Course of interferon beta-1b (Betaferon (R)) therapy in patients with relapsing-remitting multiple sclerosis. Survey results

      NERVENARZT
    12. Hummel, V; Kallmann, BA; Wagner, S; Fuller, T; Bayas, A; Tonn, JC; Benveniste, EN; Toyka, KV; Rieckmann, P
      Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    13. Mohr, DC; Cox, D
      Multiple sclerosis: Empirical literature for the clinical health psychologist

      JOURNAL OF CLINICAL PSYCHOLOGY
    14. Mohan, N; Edwards, ET; Cupps, TR; Oliverio, PJ; Sandberg, G; Crayton, H; Richert, JR; Siegel, JN
      Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides

      ARTHRITIS AND RHEUMATISM
    15. Koppel, RA; Boh, EE
      Cutaneous reactions to chemotherapeutic agents

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    16. Schreiber, K; Sorensen, PS; Koch-Henriksen, N; Wagner, A; Blinkenberg, M; Svarer, C; Petersen, HC
      Correlations of brain MRI parameters to disability in multiple sclerosis

      ACTA NEUROLOGICA SCANDINAVICA
    17. Corsini, E; La Mantia, L; Gelati, M; Dufour, A; Milanese, C; Massa, G; Nespolo, A; Salmaggi, A
      Long-term immunological changes in azathioprine-treated MS patients

      NEUROLOGICAL SCIENCES
    18. Feinstein, A
      Multiple sclerosis, disease modifying treatments and depression: a critical methodological review

      MULTIPLE SCLEROSIS
    19. Richert, ND; Zierak, MC; Bash, CN; Lewis, BK; McFarland, HF; Frank, JA
      MRI and clinical activity in MS patients after terminating treatment with interferon beta-1b

      MULTIPLE SCLEROSIS
    20. Chofflon, M
      Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials

      EUROPEAN JOURNAL OF NEUROLOGY
    21. Maurer, M; Rieckmann, P
      Relapsing-remitting multiple sclerosis - What is the potential for combination therapy?

      BIODRUGS
    22. Polman, CH; Uitdehaag, BMJ
      Regular review - Drug treatment of multiple sclerosis

      BRITISH MEDICAL JOURNAL
    23. Tourbah, A; Berry, I
      Contribution of magnetic resonance to multiple sclerosis

      PATHOLOGIE BIOLOGIE
    24. Montalban, X; Duran, I; Rio, J; Saez-Torres, I; Tintore, M; Martinez-Caceres, EM
      Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta?

      JOURNAL OF NEUROLOGY
    25. Brown, MG; Murray, TJ; Sketris, IS; Fisk, JD; LeBlanc, JC; Schwartz, CE; Skedgel, C
      Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression - First estimation

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    26. Kobelt, G; Jonsson, L; Henriksson, F; Fredrikson, S; Jonsson, B
      Cost-utility analysis of interferon beta-1b in secondary progressive multiple sclerosis

      INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
    27. Polman, CH; Uitdehaag, BMJ
      Drug treatment of multiple sclerosis

      WESTERN JOURNAL OF MEDICINE
    28. Noseworthy, JH; Lucchinetti, C; Rodriguez, M; Weinshenker, BG
      Medical progress: Multiple sclerosis.

      NEW ENGLAND JOURNAL OF MEDICINE
    29. Kita, M; Goodkin, DE; Bacchetti, P; Waubant, E; Nelson, SJ; Majumdar, S
      Magnetization transfer ratio in new MS lesions before and during therapy with IFN beta-1a

      NEUROLOGY
    30. Zhao, GJ; Koopmans, RA; Li, DKB; Bedell, L; Paty, DW
      Effect of interferon beta-1b in MS - Assessment of annual accumulation of PD/T2 activity on MRI

      NEUROLOGY
    31. Pender, MP
      4: Multiple sclerosis

      MEDICAL JOURNAL OF AUSTRALIA
    32. Gerschlager, W; Beisteiner, R; Deecke, L; Dirnberger, G; Endl, W; Kollegger, H; Lindinger, G; Vass, K; Lang, W
      Electrophysiological. neuropsychological and clinical findings in multiplesclerosis patients receiving interferon beta-1b: A 1-year follow-up

      EUROPEAN NEUROLOGY
    33. Molyneux, PD; Kappos, L; Polman, C; Pozzilli, C; Barkhof, F; Filippi, M; Yousry, T; Hahn, D; Wagner, K; Ghazi, M; Beckmann, K; Dahlke, F; Losseff, N; Barker, GJ; Thompson, AJ; Miller, DH
      The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

      BRAIN
    34. Lane, WJ; Dias, S; Hattori, K; Heissig, B; Choy, M; Rabbany, SY; Wood, J; Moore, MAS; Rafii, S
      Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases

      BLOOD
    35. Janardhan, V; Bakshi, R
      Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis

      ARCHIVES OF NEUROLOGY
    36. Arbizu, T; Alvarez-Cermeno, JC; Decap, G; Fernandez, O; Uria, DF; Merino, AG; Izquierdo, G; Montalban, X
      Interferon beta-1b treatment in patients with relapsing-remitting multiplesclerosis under a standardized protocol in Spain

      ACTA NEUROLOGICA SCANDINAVICA
    37. Calabresi, PA; Martin, R; Jacobson, S
      Chemokines in chronic progressive neurological diseases: HTLV-1 associatedmyelopathy and multiple sclerosis

      JOURNAL OF NEUROVIROLOGY
    38. Sorensen, PS
      Biological markers in body fluids for activity and progression in multiplesclerosis

      MULTIPLE SCLEROSIS
    39. Smith, PF; Darlington, CL
      Recent developments in drug therapy for multiple sclerosis

      MULTIPLE SCLEROSIS
    40. Heesen, C; Hauer, S; Hadji-Abdolrahim, B; Berenbeck, C; Buhmann, C; Emskotter, T
      Current status of multiple sclerosis therapy in Germany: a national survey

      EUROPEAN JOURNAL OF NEUROLOGY
    41. Noseworthy, JH; Gold, R; Hartung, HP
      Treatment of multiple sclerosis: recent trials and future perspectives

      CURRENT OPINION IN NEUROLOGY
    42. Berman, NEJ; Marcario, JK; Yong, C; Raghavan, R; Raymond, LAM; Joag, SV; Narayan, O; Cheney, PD
      Microglial activation and neurological symptoms in the SIV model of neuroAIDS: Association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes

      NEUROBIOLOGY OF DISEASE
    43. Conlon, P; Oksenberg, JR; Zhang, JQ; Steinman, L
      The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system

      NEUROBIOLOGY OF DISEASE
    44. Mohr, DC; Goodkin, DE
      Treatment of depression in multiple sclerosis: Review and meta-analysis

      CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE
    45. Pender, MP
      Recent progress in the diagnosis and treatment of multiple sclerosis

      JOURNAL OF CLINICAL NEUROSCIENCE
    46. Hohlfeld, R
      Therapeutic strategies in multiple sclerosis. I. Immunotherapy

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    47. Metz, LM; Patten, SB; McGowan, D
      Symptomatic therapies of multiple sclerosis

      BIOMEDICINE & PHARMACOTHERAPY
    48. Gelati, M; Corsini, E; Dufour, A; Massa, G; La Mantia, L; Milanese, C; Nespolo, A; Salmaggi, A
      Immunological effects of in vivo interferon-beta(1b) treatment in ten patients with multiple sclerosis: a 1-year follow-up

      JOURNAL OF NEUROLOGY
    49. Moriarty, DM; Blackshaw, AJ; Talbot, PR; Griffiths, HL; Snowden, JS; Hillier, VF; Capener, S; Laitt, RD; Jackson, A
      Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images

      AMERICAN JOURNAL OF NEURORADIOLOGY
    50. Lichtinghagen, R; Seifert, T; Kracke, A; Marckmann, S; Wurster, U; Heidenreich, F
      Expression of matrix metalloproteinase-9 and its inhibitors in mononuclearblood cells of patients with multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    51. Bourdette, D; Antel, J; McFarland, H; Montgomery, E
      Monitoring relapsing remitting MS patients

      JOURNAL OF NEUROIMMUNOLOGY
    52. Cohen, JA; Carter, JL; Kinkel, RP; Schwid, SR
      Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders

      JOURNAL OF NEUROIMMUNOLOGY
    53. Ossege, LM; Sindern, E; Voss, B; Malin, JP
      Immunomodulatory effects of IFN beta-1b on the mRNA-expression of TGF beta-1 and TNF alpha in vitro

      IMMUNOPHARMACOLOGY
    54. Arnason, BGW
      Immunologic therapy of multiple sclerosis

      ANNUAL REVIEW OF MEDICINE
    55. Trojano, M; Avolio, C; Liuzzi, GM; Ruggieri, M; Defazio, G; Liguori, M; Santacroce, MP; Paolicelli, D; Giuliani, F; Riccio, P; Livrea, P
      Changes of serum sICAM-1 and MMP-9 induced by rIFN beta-1b treatment in relapsing-remitting MS

      NEUROLOGY
    56. Simon, JH; Jacobs, LD; Campion, MK; Rudick, RA; Cookfair, DL; Herndon, RM; Richert, JR; Salazar, AM; Fischer, JS; Goodkin, DE; Simonian, N; Lajaunie, M; Miller, DE; Wende, K; Martens-Davidson, A; Kinkel, RP; Munschauer, FE; Brownscheidle, CM
      A longitudinal study of brain atrophy in relapsing multiple sclerosis

      NEUROLOGY
    57. Zimmermann, C; Walther, EU; Goebels, N; Lienert, C; Kappos, L; Hartung, HP; Hohlfeld, R
      Interferon beta-1b for treatment of secondary progressive multiple sclerosis

      NERVENARZT
    58. Buttner, U; Chofflon, M; Hess, K; Kappos, L; Kesselring, J; Ludin, H; Rihs, F; Schluep, M; Vaney, C; Baumhackl, U; Berger, T; Freimuller, O; Hartung, HP; Kollegger, W; Kristoferitsch, W; Vass, K; Lassmann, H; Markut, S; Altenkirch, H; Boese, J; Gehlen, W; Goebels, N; Gold, R; Haas, J; Haferkamp, G; Heidenreic, F; Heitmann, R; Hohlfeld, R; Jugelt, E; Kolmel, H; Konig, N; Lowitzsch, K; Manegold, U; Mertin, J; Pette, M; Poser, S; Sailer, J; Schack, G; Schulz, M; Seidel, D; Stark, E; Stoll, G; Weinrich, W; Wietholter, H; Zettl, U; Zipp, F; Zschenderlein, R; Rieckmann, P; Toyka, KV; Chan, A; Bayas, A; Maurer, M; Jung, S; Gold, R; Weilbach, F; Cursiefen, S; Flachenecker, P; Rieckmann, P
      Escalating immunomodulatory therapy of multiple sclerosis

      NERVENARZT
    59. Noseworthy, JH
      Progress in determining the causes and treatment of multiple sclerosis

      NATURE
    60. Antonelli, G; Simeoni, E; Bagnato, F; Pozzilli, C; Turriziani, O; Tesoro, R; Di Marco, P; Gasperini, C; Fieschi, C; Dianzani, F
      Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    61. Rudick, RA
      Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics

      ARCHIVES OF NEUROLOGY
    62. Tselis, AC; Lisak, RP
      Multiple sclerosis - Therapeutic update

      ARCHIVES OF NEUROLOGY
    63. KOUDRIAVTSEVA T; POZZILLI C; FIORELLI M; GASPERINI C; BAGNATO F; GALGANI S; FRONTONI M; CICCARELLI O; BASTIANELLO S
      DETERMINANTS OF GD-ENHANCED MRI RESPONSE TO IFN-BETA-I A TREATMENT INRELAPSING-REMITTING MULTIPLE-SCLEROSIS

      Multiple sclerosis
    64. GAINES AR; VARRICCHIO F
      INTERFERON BETA-1B INJECTION SITE REACTIONS AND NECROSES

      Multiple sclerosis
    65. LIBLAU RS; FONTAINE B
      RECENT ADVANCES IN IMMUNOLOGY IN MULTIPLE-SCLEROSIS

      Current opinion in neurology
    66. Compston, A
      Future options for therapies to limit damage and enhance recovery

      SEMINARS IN NEUROLOGY
    67. FERRARINI AM; SIVIERI S; BULIAN P; BUTTARELLO M; BIASI G; TAVOLATO B; GALLO P
      TIME-COURSE OF INTERLEUKIN-2 RECEPTOR EXPRESSION IN INTERFERON BETA-TREATED MULTIPLE-SCLEROSIS PATIENTS

      Journal of neuroimmunology
    68. Ossege, LM; Sindern, E; Patzold, T; Malin, JP
      Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta 1 and its receptor type II

      JOURNAL OF NEUROIMMUNOLOGY
    69. RIO J; NOS C; MARZO ME; TINTORE M; MONTALBAN X
      LOW-DOSE STEROIDS REDUCE FLU-LIKE SYMPTOMS AT THE INITIATION OF IFN-BETA-1B IN RELAPSING-REMITTING MS

      Neurology
    70. VANOOSTEN BW; TRUYEN L; BARKHOF F; POLMAN CH
      CHOOSING DRUG-THERAPY FOR MULTIPLE-SCLEROSIS - AN UPDATE

      Drugs
    71. Leppert, D; Ford, J; Stabler, G; Grygar, C; Lienert, C; Huber, S; Miller, KM; Hauser, SL; Kappos, L
      Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

      BRAIN
    72. KIVISAKK P; LUNDAHL J; VONHEIGL Z; FREDRIKSON S
      NO EVIDENCE FOR INCREASED FREQUENCY OF AUTOANTIBODIES DURING INTERFERON-BETA(1B) TREATMENT OF MULTIPLE-SCLEROSIS

      Acta neurologica Scandinavica
    73. LUBETZKI C
      NEW TREATMENTS

      La Presse medicale
    74. ZAVALISHIN IA; YAKHNO NN; ZHUCHENKO TD; NIYAZBEKOVA AS
      BETAFERON - FIRST EXPERIENCE OF APPLICATI ON IN TREATMENT OF MULTIPLE-SCLEROSIS IN RUSSIA

      Zurnal nevropatologii i psihiatrii im. S.S. Korsakova
    75. SCHLUEP M; BOGOUSSLAVSKY J
      EMERGING TREATMENTS IN MULTIPLE-SCLEROSIS

      European neurology
    76. TALBOT PJ; PAQUETTE JS; CIURLI C; ANTEL JP; OUELLET F
      MYELIN BASIC-PROTEIN AND HUMAN CORONAVIRUS 229E CROSS-REACTIVE T-CELLS IN MULTIPLE-SCLEROSIS

      Annals of neurology
    77. DHIBJALBUT S; JIANG H; WILLIAMS GJ
      THE EFFECT OF INTERFERON BETA-1-BETA ON LYMPHOCYTE ENDOTHELIAL-CELL ADHESION

      Journal of neuroimmunology
    78. SIMON JH
      MAGNETIC-RESONANCE-IMAGING OF MULTIPLE-SCLEROSIS LESIONS MEASURING OUTCOME IN TREATMENT TRIALS

      Western journal of medicine
    79. HUGHES RAC; SHARRACK B
      MORE IMMUNOTHERAPY FOR MULTIPLE-SCLEROSIS

      Journal of Neurology, Neurosurgery and Psychiatry
    80. MILO R; PANITCH H
      ADDITIVE EFFECTS OF COPOLYMER-1 AND INTERFERON BETA-1B ON THE IMMUNE-RESPONSE TO MYELIN BASIC-PROTEIN

      Journal of neuroimmunology
    81. JIANG H; MILO R; SWOVELAND P; JOHNSON KP; PANITCH H; DHIBJALBUT S
      INTERFERON-BETA-1B REDUCES INTERFERON GAMMA-INDUCED ANTIGEN-PRESENTING CAPACITY OF HUMAN GLIAL AND B-CELLS

      Journal of neuroimmunology
    82. ARNASON BGW; REDER AT
      INTERFERONS AND MULTIPLE-SCLEROSIS

      Clinical neuropharmacology
    83. PANITCH HS; BEVER CT
      CLINICAL-TRIALS OF INTERFERONS IN MULTIPLE-SCLEROSIS - WHAT HAVE WE LEARNED

      Journal of neuroimmunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 10:54:39